It has been reported that the high expression of METTL3 in HCC leads to higher m6A methylation levels of SOCS2 and decreases SOCS2 mRNA expression by degrading SOCS2 mRNA transcripts through a YTHDF2-dependent pathway (Chen et al., 2018). The gene discussed is METTL3; the disease is hepatocellular carcinoma.